Revance Therapeutics

Revance Therapeutics shares soar on takeover by Crown Labs

Markewatch

Mon, 08/12/24 - 11:41 am

Crown Laboratories

M&A

AbbVie expects Botox to maintain market share as competition heats up

Reuters

Wed, 01/10/24 - 06:24 pm

US consumer group seeks stronger warnings on Botox, similar treatments

Reuters

Tue, 12/12/23 - 10:02 am

Supernus Pharmaceuticals

Myobloc

Galderma

Dysport

Revance rolls out a price drop for Daxxify as it tries to challenge AbbVie's Botox

Fierce Pharma

Wed, 09/20/23 - 08:57 am

FDA Decisions 2023: Sandoz, Gilead Sciences and More

BioSpace

Fri, 08/25/23 - 11:31 am

FDA Action Alert: Ipsen, Revance, Neurocrine and Regeneron

BioSpace

Mon, 08/14/23 - 11:29 am

fibrodysplasia ossificans progressiva

Revance wants you to 'Break Up With Botox' as it goes to war with AbbVie in new anti-wrinkle market battle

Fierce Pharma

Mon, 07/3/23 - 10:44 am

Goldman Sachs says this biotech working on a Botox rival drug could rally nearly 30%

CNBC

Fri, 09/23/22 - 10:52 am

AbbVie unveils 'See Yourself' Botox campaign, days after new rival approved

Endpoints

Tue, 09/13/22 - 08:06 pm

Longer-lasting Botox competitor nabs FDA approval — can it compete with AbbVie's $2B cash cow?

Endpoints

Thu, 09/8/22 - 11:04 am

Go or no go? Bristol’s Tyk2 test

EP Vantage

Wed, 08/31/22 - 10:15 am

FDA

Bristol Myers Squibb

deucravacitinib

Amylyx Pharmaceuticals

ALS

AMX0035

Ferring Pharmaceuticals

Spectrum Pharmaceuticals

JNJ

Oncopeptides

Revance Receives FDA Acceptance of BLA Resubmission for DaxibotulinumtoxinA for Injection for Glabellar Lines

BioSpace

Fri, 04/22/22 - 10:15 am

Revance's Botox rival turned away by FDA after inspectors flagged manufacturing 'deficiencies'

Fierce Pharma

Mon, 10/18/21 - 11:10 am

Growing Opportunities – The Latest Job Expansions in the Life Sciences Industry

BioSpace

Tue, 12/1/20 - 11:01 am

Cold Chain Technologies

August Bioservices

Halda

Revance CEO stepping down over 'misjudgment'

Biopharma Dive

Mon, 10/14/19 - 11:51 pm

Revance Therapeutics

Dan Browne

Xtalks

Mon, 03/5/18 - 11:10 am

Look out, Allergan: Doctor surveys show the 'Botox competitive threat is real'

Fierce Pharma

Fri, 01/19/18 - 10:03 am

The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter

Stat

Tue, 10/3/17 - 11:50 am

Global Blood Therapeutics

Biotech IPOs: Class of 2014 still rolling as investors line up to cash in

Fierce Biotech

Fri, 02/14/14 - 01:09 pm

biotech

IPOs

Dicerna Pharmaceuticals

IPO boom: 8 biotechs bag half a billion in a banner week

Fierce Biotech

Fri, 02/7/14 - 10:59 am

IPOs

Argos Therapeutics

Eleven Biotherapeutics

Revance Therapeutics

Egalet

uniQure

Auspex Pharmaceuticals

Genocea Biosciences

Biocept

Search form

You are here

Revance Therapeutics